Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2.
What Chicago community organizations needed to implement COVID-19 interventions: lessons learned in 2021.
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer.
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
See All 33 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Chaney, Mark
One or more keywords matched the following items that are connected to
Chaney, Mark
Item Type
Name
Concept
Hospital Rapid Response Team
Academic Article
Commentary: Is it time for a rapid kidney response team?
Search Criteria
Hospital Rapid Response Team